Great Point Partners LLC Silence Therapeutics PLC Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$2.65 - $29.85 $881,215 - $9.93 Million
-332,534 Reduced 82.83%
68,915 $692,000
Q2 2022

Aug 15, 2022
SELL
$7.99 - $19.5 $343,522 - $838,383
-42,994 Reduced 9.67%
401,449 $4.76 Million
Q4 2021

Feb 14, 2022
BUY
$20.61 - $25.71 $9.16 Million - $11.4 Million
444,443 New
444,443 $10.6 Million

Others Institutions Holding SLN

# of Institutions
72
Shares Held
28.1M
Call Options Held
300
Put Options Held
2K
View Full List

About Silence Therapeutics plc

SLN Quotes by TradingView
  • Ticker SLN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,888,400
  • Market Cap $184M
  • Description
  • Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...
More about SLN
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email